GlassScriptPhysician profile
Douglas Edwin Henrich
NPI 1588634414
$3,520.38
in general payments reported to CMS, 2019-2025
14 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $143 · 2021: $638 · 2022: $635 · 2023: $786 · 2024: $631 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,963.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,226.94 | 2021-2025 | Inspire |
| Smith+Nephew, INC. | $330.18 | 2019-2025 | Tula, Rf20000, Coblation |
| Stryker Corporation | $321.72 | 2019-2022 | |
| Aerin Medical INC. | $169.49 | 2019-2025 | |
| Hologic Sales and Service, LLC | $112.00 | 2024 | Coolseal Generator |
| Genzyme Corporation | $69.52 | 2021-2022 | |
| Karl Storz Endoscopy-America | $61.73 | 2020-2025 | |
| Acclarent, INC | $57.45 | 2021-2024 | Acclarent Aera |
| Zimmer Biomet Holdings, INC. | $43.34 | 2022-2023 | Omnimax |
| Intersect Ent, INC. | $36.73 | 2019-2021 | |
| Alk-Abello, INC | $34.81 | 2025 | Standardized Mite D. Farinae, Timothy, Standardized, Alternaria Tenuis |
| Glaxosmithkline, LLC. | $28.77 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $15.35 | 2025 | |
| Merck Sharp & Dohme LLC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Henrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.